Managing Director Of AstraZeneca, Mark Fladrich Featured In Top Business Title, The CEO Magazine

Mark Fladrich spoke with The CEO Magazine in an exclusive interview on his successful career at Australia's leading pharmaceutical company

by Paris Brooks

(WireNews+Co) - Sydney, Australia - 19 March 2012

Manufacturing pharmaceuticals is a specialised industry that requires a great deal of understanding. Rigorous research and development, plus stringent government regulation, mean executives within this sector need to be both knowledgeable and diligent. More than any other industry, pharmaceutical companies face a myriad of challenges to remain competitive and successful.

Managing the Australian and New Zealand businesses, Mark Fladrich is Managing Director for AstraZeneca. “I have been working for AstraZeneca since the early 90s. I have recently returned home toAustraliaafter working inEuropein several senior commercial and corporate roles.

“In these positions, I was involved in launching quite a few new medicines. This experience was great because I got to work with many of our larger marketing companies. I did quite a lot of work on the interface between commercial and research and development, and on the operational side, bringing new products to the market.”

To read the entire interview click here (http://www.beanmedia.com.au/profiles/Astra-Zeneca.pdf)

The CEO Magazine is Australia’s leading business magazine focused directly at high-level executives. The CEO Magazine is of unrivalled quality and has a hugely-influential readership of Australia's top businessmen and women. The CEO Magazine holds a prestigious partnership with a number of leading Australian airlines and can be seen in every Virgin and Qantas Business Lounge across Australia as well as all Hilton Hotels nationwide.